This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aprogen Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovations of Ho-Min Kim
Introduction
Ho-Min Kim is a notable inventor based in Kyungju, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His work focuses on enhancing the understanding of vascular biology and therapeutic applications.
Latest Patents
Ho-Min Kim holds 1 patent related to his innovative research. His patent, titled "Fusion proteins binding to VEGF and angiopoietin," discloses an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and Angiopoietin polypeptide. This invention includes a nucleotide sequence encoding a Tie2 component and a VEGFR component, which has potential implications in treating various diseases.
Career Highlights
Ho-Min Kim is currently associated with Aprogen Inc., where he continues to advance his research in biotechnology. His work has been instrumental in developing new therapeutic strategies that target critical pathways in disease progression.
Collaborations
Throughout his career, Ho-Min Kim has collaborated with esteemed colleagues, including Hak-Zoo Kim and Young Jun Koh. These partnerships have fostered a collaborative environment that enhances innovation and research output.
Conclusion
Ho-Min Kim's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile